Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axis
Author:
Affiliation:
1. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China
2. Department of Thoracic Surgery, Shengjing Hospital of China Medical University, Shenyang, China
Publisher
Informa UK Limited
Subject
Cell Biology,Developmental Biology,Molecular Biology
Link
https://www.tandfonline.com/doi/pdf/10.1080/15384101.2018.1556058
Reference25 articles.
1. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management
2. Compendium of TCDD-mediated transcriptomic response datasets in mammalian model systems
3. Possible aryl hydrocarbon receptor-independent pathway of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced antiproliferative response in human breast cancer cells
4. Progesterone receptor is involved in 2,3,7,8-tetrachlorodibenzo- p -dioxin-stimulated breast cancer cells proliferation
5. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated deregulation of myeloid and sebaceous gland stem/progenitor cell homeostasis
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer;Pathology - Research and Practice;2024-11
2. Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer;Non-coding RNA Research;2024-03
3. DNMT1 regulates hypermethylation and silences hsa_circ_401351 in hydroquinone‐induced malignant TK6 cells;Environmental Toxicology;2023-12-18
4. Recent advances in novel miRNA mediated approaches for targeting breast cancer;Journal of Drug Targeting;2023-08-01
5. Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer;Functional & Integrative Genomics;2023-07-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3